SR Medical swings to FY26 H1 net loss of HK$68.62 million; revenue rises 30.7% to HK$223.14 million

• SR Medical Technology posted revenue of HK$223.14 million, up 30.7% year over year.
• Loss attributable to shareholders swung to HK$70.6 million; basic and diluted loss per share was HK$0.02.
• Loss before tax widened to HK$69.07 million, pressured by higher other operating costs and finance costs.
• Digital healthcare services generated HK$65.58 million of revenue following the Doctor Chunyu acquisition completed on March 11, 2026.
• Property investment, operation and management revenue slipped to HK$157.56 million; net debts rose to HK$2.79 billion, lifting gearing to 129.9%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SR Medical Technology Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260831-12309616), on August 31, 2026, and is solely responsible for the information contained therein.